Sitagliptin Combined With Gemcitabine and Albumin-bound Paclitaxel in PDAC Patients

NCT05947825 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

30

Enrollment

OTHER

Sponsor class

Conditions

PDAC - Pancreatic Ductal Adenocarcinoma

Interventions

DRUG: Combination of sitagliptin+ gemcitabine + nab-paclitaxel

Sponsor

Tianjin Medical University Cancer Institute and Hospital